GeneSight

GeneSight is a genetic test that helps healthcare providers take a personalized approach to prescribing medicine for patients.  Because genes influence the way a person’s body responds to specific medications, the medications may not work the same for everyone. Using DNA gathered with a simple cheek swab, GeneSight analyzes a patient’s genes and provides individualized information to help healthcare providers select medications that better match their patient’s genes. Multiple clinical studies have shown that when clinicians used GeneSight to help guide treatment decisions, patients were up to twice as likely to respond to the selected medication compared to standard of care.1

GeneSight Psychotropic

For people who have been diagnosed with depression, PTSD, anxiety or other conditions

GeneSight Psychotropic

analyzes genes that can affect a patient’s response to antidepressant and antipsychotic medications
Learn More

GeneSight Analgesic

For people who have been diagnosed with acute or chronic pain

GeneSight Analgesic

analyzes how patients’ genes can affect possible response to opioids, NSAIDs and muscle relaxants
Learn More

GeneSight ADHD

For people who have been diagnosed with ADHD

GeneSight ADHD

analyzes genes that can affect a patient’s response to medications prescribed to treat ADHD
Learn More

GeneSight MTHFR

For information about your body's folic acid conversion

GeneSight MTHFR

tests for genetic causes of folate deficiency, which may be more prevalent among depressed patients
Learn More
Reference:
1. Hall-Flavin DK, Winner JG, Allen JD, Carhart JM, Proctor B, Snyder KA, Drews MS, Eisterhold LL, Geske J, Mrazek DA. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenetics and Genomics. 2013;23(10):535-548.